Beacon ADC

Benefit from the most complete clinical trial and drug landscape for ADCs

What we cover

Beacon ADC is a manually curated database solution that includes clinical trial and drug records for preclinical, active, approved and discontinued:

  • ADC (Antibody Drug Conjugates)
  • Immunotoxins
  • SDMCs (Small Molecule Drug Conjugates)
  • Radioimmunoconjugates
  • Ligand Conjugated Nanoparticles
  • Liposomal Drug Conjugate and other comparable
  • modalities

How it helps

Here are a few example use cases that have benefitted our clients in accelerating their ADC development programs:

  • Benchmark drug development and clinical trial strategies against competitors.
  • Getting an in-depth competitive landscape overview of the competitors and their assets in the clinic.
  • Drastically reduce manual research time with our database solution which allows users to rapidly assemble data for analysis on targets, payloads and much more.
  • Identify new players and new assets in entering the clinic and monitor their progress.

How Beacon ADC works

Search the trial and drug landscape by linker, payload and target alongside 20 other search criteria including disease, line of therapy, biomarker, sponsor etc. Instantly extract the data points you need to conduct more complex analysis.

How we target the data

We house all publicly available sources of data updated with 24 – 48 hours of publication proactively. Our sources cover (but are not limited to):

  • Clinical Trials Registries
  • Scientific Journals and Publications
  • Company Reports and Presentations
  • Press Releases
  • Conference Reports and Abstracts
  • Government and Regulatory Organizations
  • Newspapers and other media
  • Patents

Related content

ADC Infographic 2021

Find out more

ADC Infographic 2021

Find out more

ADC Webinar 2020

Find out more

What our customers say

“I look forward to using Beacon. It saves me hours of trawling through false positive results to my searches.”

Head of Competitive Intelligence
Multinational Pharmaceutical Company

Our ADC Expert


Jia He, PhD is the lead research analyst for ADCs in the Beacon Targeted Therapies teams.

Sign up to her weekly newsletter with the latest ADC landscape with data from Beacon ADC.

Subscribe to newsletter

Other Beacon Solutions

Adoptive Cell
Cancer Vaccine
Gene Therapy
Oncolytic Viruses
Beacon Adoptive Cell Logo


Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

Beacon Bispecific Logo


Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021


Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

Beacon Checkpoint Logo


Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more


Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon DDR Logo


Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

Beacon Gene Therapy Logo


From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more


Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon Oncolytic Viruses Logo


From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

Beacon TPD Logo


Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more

Any questions? Contact us

To speak to one of our team more about how we can tailor Beacon ADC to help you, get in touch with our Account Manager.



Jake Morris

ADC Account Manager

Contact the Team

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.